会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
    • 具有用于受控药物递送和调节的生物相容性的多孔聚合物区域的医疗装置
    • US08535702B2
    • 2013-09-17
    • US11048616
    • 2005-02-01
    • Robert E. RichardFrederick H. StricklerMarlene C. SchwarzRudolf FaustShrirang V. RanadeMichael N. Helmus
    • Robert E. RichardFrederick H. StricklerMarlene C. SchwarzRudolf FaustShrirang V. RanadeMichael N. Helmus
    • A61F2/00
    • A61L31/129A61L27/48A61N1/05
    • The present invention relates to phase separated polymeric regions and to their use in conjunction with implantable or insertable medical devices. In some aspects of the invention, phase separated polymeric regions are provided that include (a) at least one biostable polymeric phase and (b) at least one biodisintegrable polymeric phase, which is of nanoscale dimensions and which undergoes biodisintegration such that the phase separated polymeric region becomes a nanoporous polymeric region in vivo. Other aspects of the invention are directed to methods of making implantable or insertable medical devices having at least one nanoporous polymeric region. These methods include (a) providing a phase separated polymeric region comprising a stable polymeric phase and a disintegrable polymeric phase of nanoscale dimensions, (b) selectively removing the disintegrable polymeric phase thereby producing the nanoporous polymeric region. In still other aspects, implantable or insertable medical devices are provided which have phase separated polymeric regions that include (a) at least one block copolymer having at least one biostable polymer block and at least one biodisintegrable polymer block and (b) at least one therapeutic agent which is released in vivo upon implantation or insertion of the medical device.
    • 本发明涉及相分离的聚合物区域以及它们与可植入或可插入的医疗装置结合使用。 在本发明的一些方面,提供了相分离的聚合物区域,其包括(a)至少一个生物稳定的聚合物相和(b)至少一个具有纳米级尺寸并且经历生物整合的生物分解聚合物相,并且经历相分离的聚合物 区域在体内成为纳米孔聚合物区域。 本发明的其它方面涉及制造具有至少一个纳米多孔聚合物区域的可植入或可插入医疗器械的方法。 这些方法包括(a)提供包含稳定聚合物相和纳米尺度的可分解聚合物相的相分离聚合物区域,(b)选择性地除去可分解的聚合物相,从而制备纳米多孔聚合物区域。 在另外的方面,提供了可植入或可插入的医疗装置,其具有相分离的聚合物区域,其包括(a)至少一种具有至少一种生物稳定聚合物嵌段和至少一种生物可分解聚合物嵌段的嵌段共聚物和(b)至少一种治疗 在植入或插入医疗装置时在体内释放的药剂。
    • 7. 发明申请
    • Processes for producing polymer coatings through surface polymerization
    • 通过表面聚合生产聚合物涂层的方法
    • US20080145516A1
    • 2008-06-19
    • US12070275
    • 2008-02-14
    • Robert A. HerrmannFrederick H. StricklerWendy NaimarkPeter L. Dayton
    • Robert A. HerrmannFrederick H. StricklerWendy NaimarkPeter L. Dayton
    • B05D3/10A61F2/82
    • A61L31/10A61L31/16A61L2300/606
    • A medical device with a therapeutic agent-releasing polymer coating. The medical device is provided by a method that comprises: (a) attaching at least one reactive species to a medical device surface, which reactive species leads to chain growth polymerization in the presence of monomer; (b) contacting the reactive species with at least one monomer species, thereby forming a polymer coating on the surface of the medical device; and (c) providing at least one therapeutic agent within the polymer coating. The therapeutic agent may be incorporated during formation of the polymer coating or after formation of the polymer coating. The at least one reactive species can comprise, for example, a free radical species, a carbanion species. a carbocation species, a Ziegler-Natta polymerization complex, a metallocene complex, and/or an atom transfer radical polymerization initiator. Alternatively, the medical device is provided by a process comprising: (a) immobilizing least one polymerization catalyst at a medical device surface, which polymerization catalyst leads to polymerization in the presence of monomer; (b) contacting the medical device surface with at least one monomer species, thereby forming a polymer coating at the surface of the medical device; and (c) providing at least one therapeutic agent within the polymer coating.
    • 具有治疗剂释放聚合物涂层的医疗装置。 该医疗装置由一种方法提供,该方法包括:(a)将至少一种反应性物质附着到医疗器械表面上,该反应性物质在单体存在下导致链增长聚合; (b)使反应性物质与至少一种单体物质接触,从而在医疗装置的表面上形成聚合物涂层; 和(c)在聚合物涂层内提供至少一种治疗剂。 治疗剂可以在形成聚合物涂层期间或在形成聚合物涂层之后引入。 至少一种反应性物质可以包含例如自由基物质,碳负离子物质。 碳阳离子种类,齐格勒 - 纳塔聚合络合物,茂金属络合物和/或原子转移自由基聚合引发剂。 或者,医疗装置由包括以下步骤的方法提供:(a)在医疗器械表面固定最少一种聚合催化剂,该聚合催化剂在单体存在下导致聚合; (b)使医疗器械表面与至少一种单体物质接触,从而在医疗装置的表面形成聚合物涂层; 和(c)在聚合物涂层内提供至少一种治疗剂。
    • 10. 发明授权
    • Implantable or insertable medical devices containing graft copolymer for controlled delivery of therapeutic agents
    • 含有接受共聚物的植入式或可插入医疗器械用于治疗剂的控制递送
    • US07357940B2
    • 2008-04-15
    • US10632413
    • 2003-07-31
    • Robert E. RichardFrederick H. Strickler
    • Robert E. RichardFrederick H. Strickler
    • A61F13/00
    • A61L31/16A61L27/34A61L27/54A61L29/085A61L29/16A61L31/10A61L2300/602C08L51/00
    • Implantable or insertable medical devices are described. The medical devices comprise (a) a therapeutic agent and (b) a polymeric release region that controls the release of the therapeutic agent upon administration to a patient. The polymer release region comprises a graft copolymer, which further comprises a main chain and a plurality of side chains. One of (a) the main chain and (b) the side chains corresponds to a rubbery phase within the release region at ambient temperatures, while the other corresponds to a hard phase within the release layer at ambient temperatures. Typically, the graft copolymer will comprise one glass transition temperature below ambient temperature and another second glass transition temperature above ambient temperature. Also described are methods for forming the above graft copolymers, methods for administering a therapeutic agent to a patient using the above implantable or insertable medical devices, as well as methods for making the above devices.
    • 描述了可植入或可插入的医疗装置。 医疗装置包括(a)治疗剂和(b)控制治疗剂在给予患者时释放的聚合物释放区域。 聚合物释放区域包括接枝共聚物,其还包含主链和多个侧链。 (a)主链和(b)侧链对应于环境温度下释放区内的橡胶相,而另一个对应于在环境温度下释放层内的硬相。 通常,接枝共聚物将包括低于环境温度的一个玻璃化转变温度和高于环境温度的另一个第二玻璃化转变温度。 还描述了形成上述接枝共聚物的方法,使用上述可植入或可插入的医疗装置向患者施用治疗剂的方法,以及制备上述装置的方法。